NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Elite Pharmaceuticals Inc (OTCQB: ELTP)

 
ELTP Technical Analysis
1
As on 9th Jun 2023 ELTP STOCK Price closed @ 0.03 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ELTPSTOCK Price

Open 0.04 Change Price %
High 0.04 1 Day N/A N/A
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 824154 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
OTCQB USA Most Active Stocks
BMIX 0.01 %
MOBQ 0.18 %
FNMA 0.45 %
ALPP 3.56 0.00%
ALPP 3.56 0.00%
SHMP 0.06 %
NWBO 0.73 %
VPLM 0.08 %
NLST 3.72 %
SRNA 2.78 14.88%
 
OTCQB USA Top Gainers Stocks
EWLUD 0.45 275.00%
HCAND 0.02 100.00%
PMMCF 0.34 55.56%
PMMCF 0.34 55.56%
TUMIF 0.09 50.00%
EXDI 0.82 38.98%
NVMDF 0.27 35.00%
NVMDF 0.27 35.00%
GYRRF 0.24 33.33%
QTRRF 0.10 25.00%
 
OTCQB USA Top Losers Stocks
ETST 0.03 -25.00%
ETST 0.03 -25.00%
FDMSF 0.03 -25.00%
EMPR 19.46 -20.73%
EMPR 19.46 -20.73%
IFNY 0.04 -20.00%
UBMRD 0.56 -15.15%
HARY 0.06 -14.29%
HARY 0.06 -14.29%
NPDCF 0.06 -14.29%
 
 
ELTP
Daily Charts
ELTP
Intraday Charts
Whats New @
Bazaartrend
ELTP
Free Analysis
 
ELTP Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
ELTP Forecast October 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
ELTP Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
ELTP Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
ELTP Other Details
Segment EQ
Market Capital 39439920.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
ELTP Address
ELTP
 
ELTP Latest News
 
Your Comments and Response on Elite Pharmaceuticals Inc
 
ELTP Business Profile
Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets for pains under the Dilaudid brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Methadone HCl tablets for pains under the Dolophine brand; and Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; and SequestOX, an immediate release Oxycodone with Naltrexone. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. It has a manufacturing and license agreement with Epic Pharma LLC; development and license agreement with SunGen Pharma, LLC; and strategic marketing alliance with Glenmark Pharmaceuticals, Inc. USA, as well as Lannett Company. Inc. The company was founded in 1984 and is headquartered in Northvale, New Jersey. Address: 165 Ludlow Avenue, Northvale, NJ, United States, 07647
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service